2023 Q2 Form 10-Q Financial Statement
#000154812323000099 Filed on May 10, 2023
Income Statement
| Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| Revenue | |||
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $23.07K | $26.97K | $57.64K |
| YoY Change | -60.12% | -53.21% | -83.72% |
| % of Gross Profit | |||
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | $0.00 | $0.00 | $2.020K |
| YoY Change | -100.0% | -100.0% | -23.77% |
| % of Gross Profit | |||
| Operating Expenses | $23.07K | $26.97K | $59.65K |
| YoY Change | -60.27% | -54.78% | -83.28% |
| Operating Profit | -$23.07K | -$26.97K | -$59.65K |
| YoY Change | -60.27% | -54.79% | |
| Interest Expense | $1.247K | $1.233K | |
| YoY Change | |||
| % of Operating Profit | |||
| Other Income/Expense, Net | -$1.247K | $500.00 | $3.000K |
| YoY Change | -83.33% | ||
| Pretax Income | -$24.32K | -$28.20K | -$56.65K |
| YoY Change | -58.12% | -50.22% | -84.12% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$24.32K | -$28.20K | -$56.65K |
| YoY Change | -58.12% | -50.22% | -84.12% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | $0.00 | $0.00 | $0.00 |
| Diluted Earnings Per Share | $0.00 | $0.00 | -$713.90 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 81.35M shares | 81.35M shares | 79.35M shares |
| Diluted Shares Outstanding | 81.35M shares | 81.35M shares | 79.35M shares |
Balance Sheet
| Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $29.96K | $53.03K | $2.540K |
| YoY Change | 1987.8% | -98.18% | |
| Cash & Equivalents | $29.96K | $53.03K | $2.537K |
| Short-Term Investments | |||
| Other Short-Term Assets | $6.590K | $2.540K | $5.140K |
| YoY Change | 3.78% | -50.58% | -96.1% |
| Inventory | |||
| Prepaid Expenses | $6.590K | $2.540K | |
| Receivables | $3.500K | ||
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $36.55K | $59.07K | $7.680K |
| YoY Change | 475.54% | 669.13% | -97.17% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $250.00 | ||
| YoY Change | -98.21% | ||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | |||
| YoY Change | |||
| Total Long-Term Assets | $0.00 | $0.00 | $250.00 |
| YoY Change | -100.0% | -100.0% | -98.21% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $36.55K | $59.07K | $7.680K |
| Total Long-Term Assets | $0.00 | $0.00 | $250.00 |
| Total Assets | $36.55K | $59.07K | $7.930K |
| YoY Change | 333.02% | 644.88% | -97.22% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $14.24K | $13.69K | $78.24K |
| YoY Change | -76.09% | -82.51% | 102.43% |
| Accrued Expenses | $3.479K | $2.233K | $118.7K |
| YoY Change | -97.41% | -98.12% | 157.85% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $100.0K | $100.0K | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $152.1K | $150.3K | $196.9K |
| YoY Change | -40.48% | -23.68% | 132.6% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $152.1K | $150.3K | $196.9K |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $152.1K | $150.3K | $196.9K |
| YoY Change | -40.48% | -23.68% | 109.38% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$9.752M | -$9.728M | |
| YoY Change | 0.7% | ||
| Common Stock | $81.35K | $81.35K | |
| YoY Change | 2.52% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$115.5K | -$91.23K | -$189.0K |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $36.55K | $59.07K | $7.930K |
| YoY Change | 333.02% | 644.88% | -97.22% |
Cashflow Statement
| Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$24.32K | -$28.20K | -$56.65K |
| YoY Change | -58.12% | -50.22% | -84.12% |
| Depreciation, Depletion And Amortization | $0.00 | $0.00 | $2.020K |
| YoY Change | -100.0% | -100.0% | -23.77% |
| Cash From Operating Activities | -$23.07K | -$20.17K | -$12.14K |
| YoY Change | 808.27% | 66.11% | -84.68% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | |||
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $0.00 | $3.000K |
| YoY Change | -100.0% | ||
| Cash From Investing Activities | $0.00 | $3.000K | |
| YoY Change | |||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $0.00 | ||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | 0.000 | |
| YoY Change | -100.0% | ||
| NET CHANGE | |||
| Cash From Operating Activities | -23.07K | -$20.17K | -12.14K |
| Cash From Investing Activities | 0.000 | 3.000K | |
| Cash From Financing Activities | 0.000 | 0.000 | |
| Net Change In Cash | -23.07K | -$20.17K | -9.140K |
| YoY Change | 808.27% | 120.63% | -81.44% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$23.07K | -$20.17K | -$12.14K |
| Capital Expenditures | |||
| Free Cash Flow | |||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
79348469 | shares |
| CY2023Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
usd | |
| CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
| CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
| CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
| CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
| CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
000-54808 | |
| CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
NU-MED PLUS, INC. | |
| CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
UT | |
| CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
45-3672530 | |
| CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
640 Belle Terre Rd Building 2 E | |
| CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Port Jefferson | |
| CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
| CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
11777 | |
| CY2023Q1 | dei |
City Area Code
CityAreaCode
|
(631) | |
| CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
403-4337 | |
| CY2023Q1 | dei |
Security12b Title
Security12bTitle
|
None | |
| CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
| CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
81348469 | shares |
| CY2023Q1 | us-gaap |
Cash
Cash
|
53029 | usd |
| CY2022Q4 | us-gaap |
Cash
Cash
|
73195 | usd |
| CY2023Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
3500 | usd |
| CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2540 | usd |
| CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
6350 | usd |
| CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
59069 | usd |
| CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
79545 | usd |
| CY2023Q1 | us-gaap |
Assets
Assets
|
59069 | usd |
| CY2022Q4 | us-gaap |
Assets
Assets
|
79545 | usd |
| CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
13687 | usd |
| CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
7192 | usd |
| CY2023Q1 | numd |
Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
|
34378 | usd |
| CY2022Q4 | numd |
Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
|
34378 | usd |
| CY2023Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
100000 | usd |
| CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
100000 | usd |
| CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2233 | usd |
| CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1000 | usd |
| CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
150298 | usd |
| CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
142570 | usd |
| CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
150298 | usd |
| CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
142570 | usd |
| CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
90000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
90000000 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
81348469 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
81348469 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
81348469 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
81348469 | shares |
| CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
81349 | usd |
| CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
81349 | usd |
| CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
9555087 | usd |
| CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
9555087 | usd |
| CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-9727665 | usd |
| CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-9699461 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-91229 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-63025 | usd |
| CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
59069 | usd |
| CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
79545 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6416 | usd |
| CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2961 | usd |
| CY2022Q1 | us-gaap |
Salaries And Wages
SalariesAndWages
|
12000 | usd |
| CY2023Q1 | numd |
Operating Lease Rent Expense
OperatingLeaseRentExpense
|
3300 | usd |
| CY2022Q1 | numd |
Operating Lease Rent Expense
OperatingLeaseRentExpense
|
3177 | usd |
| CY2023Q1 | us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
17255 | usd |
| CY2022Q1 | us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
39500 | usd |
| CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2015 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
26971 | usd |
| CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
59653 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-26971 | usd |
| CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-59653 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
1233 | usd |
| CY2022Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
3000 | usd |
| CY2023Q1 | us-gaap |
Other Income
OtherIncome
|
-1233 | usd |
| CY2022Q1 | us-gaap |
Other Income
OtherIncome
|
3000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28204 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-56653 | usd |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
81348469 | shares |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
79348469 | shares |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-63025 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28204 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-91229 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-132358 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-56653 | usd |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-189011 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28204 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-56653 | usd |
| CY2022Q1 | us-gaap |
Depreciation
Depreciation
|
2015 | usd |
| CY2022Q1 | numd |
Gain On Sale Of Equipment
GainOnSaleOfEquipment
|
-3000 | usd |
| CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
3084 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3500 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-3810 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-3084 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
6495 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
18500 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
6000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1233 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
21000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-20166 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12138 | usd |
| CY2022Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
3000 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
3000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-20166 | usd |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-9138 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
73195 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11675 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
53029 | usd |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2537 | usd |
| CY2023Q1 | us-gaap |
Revenue Recognition Allowances
RevenueRecognitionAllowances
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">b. Revenue Recognition</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Financial Accounting Standards Board (“FSB”) issued new guidance for the recognizing and reporting of revenue in contracts with customers. The effective date for implementation for public companies was January 1, 2018.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The new guidance established a five-step analysis to be followed when determining the recognition of revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt/115% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">1.</span></td><td><span style="font-size: 10pt">Identify the contract with a customer.</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 12pt/115% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">2.</span></td><td><span style="font-size: 10pt">Identify the performance obligations in the contract.</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 12pt/115% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">3.</span></td><td><span style="font-size: 10pt">Determine the transaction price.</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 12pt/115% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">4.</span></td><td><span style="font-size: 10pt">Allocate the transaction price to the performance obligations in the contract.</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 12pt/115% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">5.</span></td><td><span style="font-size: 10pt">Recognize revenue when, or as, the reporting organization satisfied a performance obligation.</span></td></tr></table><p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"> </p>While the Company is an early-stage company with no revenue, at the time we begin to generate revenue the Company will recognize such revenue in conformity with the guidelines set forth by ASC 606 | |
| CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">c. Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> | |
| CY2023Q1 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
500 | usd |
| CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
81348469 | shares |
| CY2023Q1 | us-gaap |
Stock Issued1
StockIssued1
|
usd | |
| CY2022Q1 | us-gaap |
Stock Issued1
StockIssued1
|
usd | |
| CY2023Q1 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
usd | |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
usd | |
| CY2023Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">h. Concentrations and Credit Risk <b><i>- </i></b>The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
| CY2023Q1 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
| CY2022Q1 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
| CY2023Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
| CY2022Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
| CY2023Q1 | numd |
Planned Expenditures
PlannedExpenditures
|
1200000 | usd |
| CY2023Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
83893 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
90368 | usd |
| CY2023Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
83893 | usd |
| CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
90368 | usd |
| CY2023Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
|
0 | usd |
| CY2022Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
|
2015 | usd |
| CY2023Q1 | us-gaap |
Sales Type Lease Revenue
SalesTypeLeaseRevenue
|
3000 | usd |
| CY2022 | us-gaap |
Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
|
3000 | usd |
| CY2011Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2011Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
90000000 | usd |
| CY2023Q1 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.001 | |
| CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
81348469 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
81348469 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
81348469 | shares |
| CY2017Q1 | numd |
Monthly Office Lease Payment
MonthlyOfficeLeasePayment
|
950 | usd |
| CY2017Q4 | numd |
Monthly Office Lease Payment
MonthlyOfficeLeasePayment
|
978 | usd |
| CY2019Q3 | numd |
Monthly Office Lease Payment
MonthlyOfficeLeasePayment
|
1008 | usd |
| CY2020Q3 | numd |
Monthly Office Lease Payment
MonthlyOfficeLeasePayment
|
1038 | usd |
| CY2021Q3 | numd |
Monthly Office Lease Payment
MonthlyOfficeLeasePayment
|
1038 | usd |
| CY2022Q3 | numd |
Monthly Office Lease Payment
MonthlyOfficeLeasePayment
|
1059 | usd |
| CY2023Q1 | numd |
Monthly Office Lease Payment
MonthlyOfficeLeasePayment
|
1000 | usd |
| CY2023Q1 | us-gaap |
Other Expenses
OtherExpenses
|
500 | usd |
| CY2023Q1 | us-gaap |
Salaries And Wages
SalariesAndWages
|
usd | |
| CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
usd | |
| CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
usd | |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
81348469 | shares |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
usd | |
| CY2023Q1 | numd |
Gain On Sale Of Equipment
GainOnSaleOfEquipment
|
usd | |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
usd | |
| CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | |
| CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
usd | |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
usd | |
| CY2023Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
usd | |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | |
| CY2022Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
| CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
| CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
| CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001543637 |
